Iq-ai Ltd Regulatory News (IQAI)

IQ-AI Ltd

("IQ-AI" or the "Company")

Imaging Biometrics and Medical College of Wisconsin Awarded Grant

Imaging Biometrics™, LLC ("IB"), a subsidiary of IQ-AI Limited (LON:IQAI), in collaboration with the Medical College of Wisconsin ("MCW"), has received a $2.75 million, five-year grant award from the National Institutes of Health - National Cancer Institute. As a participant on this grant, IB will utilise the funding to assist in the translation of machine learned, scientifically validated algorithms to software solutions that provide new clinical insight on advanced brain tumor treatment and management.

David Smith, CEO of IB, commented, "Our grant and contract development work are important stimuli at Imaging Biometrics. This grant will provide income for the Company for the next 5 years, as well as, further catalyse the development of our quantitative imaging tools, enabling us to apply the result of this collaboration with MCW to our commercial products."

The Directors of the Company accept responsibility for the contents of this announcement.

-ENDS-

For further information, please contact:

About IQ-AI Ltd 

IQ-AI, Ltd, the parent company of StoneChecker® and Imaging Biometrics®, is focused on advanced and state of the art medical software and services. (IQ-AI.ltd). Imaging Biometrics develops and provides visualization and analytical solutions that enable clinicians to better diagnose and treat diseases with greater confidence. Through close collaboration with top researchers and clinicians, sophisticated advancements are translated into platform-independent software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualization software seamlessly integrates into routine workflows. Please visit www.imagingbiometrics.com for further information.  

. 

About Imaging Biometrics™, LLC

Imaging Biometrics, a subsidiary of IQ-AI Limited (LON:IQAI), develops and provides visualization and analytical solutions that enable clinicians to better diagnose and treat diseases with greater confidence. Through close collaboration with top researchers and clinicians, sophisticated advancements are translated into platform-independent software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualization software seamlessly integrates into routine workflows. For more information about Imaging Biometrics, visit the company's website at www.imagingbiometrics.com.